On the other hand, other studies found that MIR122 levels are significantly lower in NASH patients in Western populations and that MIR122 expression decreases significantly with the progression of hepatic steatosis (23, 48). Here, MIR122 is linked to metabolic dysfunction-associated steatohepatitis.